Buy Edge Therapeutics Stock | EDGE Stock Price & Latest News | Public
EDGE

Edge Therapeutics

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    View Edge Therapeutics (EDGE) stock trends here

    About EDGE

    PDS Biotechnology Corp. engages in the development of clinical-stage immunotherapies to treat various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products PDS010...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.08
    -0.15
    -0.23
    Q2 2020
    Q3 2020
    Q4 2020
    Q1 2021

    Expected EPS
    Q1 2021

    -$0.21

    Actual EPS
    Q1 2021

    Stats

    Market Cap$58,54M
    Volume2,07k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$4.98
    1 Year Low$0.62
    Open$2.77
    High$2.78
    Low$2.63

    Buy any stock with any amount of money.

    Download the App
    Download the app